Neena Haider, PhD

OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass. Eye and Ear, and licensed to biopharmaceutical...

Ocugen, Inc. has obtained an exclusive worldwide license to develop and commercialize future ophthalmology products based on groundbreaking technology developed by Neena Haider, PhD, Associate Professor of Ophthalmology. Learn about this technology and...

As part of the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program, Neena Haider, PhD , and Hajirah Saeed, MD , met with Congress members and their legislators on September 13-14, 2017, on Capitol Hill in Washington, DC to...